Sunday, May 19, 2024
Home Research Page 6

Research

    Random

    Mustang Bio (MBIO) $3.40 Gets $7 Price Target from Cantor. (SeekingAlpha.)

    Research Editor / Curator -
    June. 20, 2019 4:30 PM ET|About: Mustang Bio, Inc. (MBIO)|By: Jason Aycock, SA News Editor  Mustang Bio (NASDAQ:MBIO) is up 8.6% after...
    Mitesco

    Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

    Research Editor / Curator -
    LIVE QUOTE Original Report: Initiating Coverage...
    @alanliverin

    Bitcoin $30,000. Time to Bargain Hunt? Read This First.

    Bitcoin Editor / Curator -
    The Bit Short: Inside Crypto’s Doomsday Machine Scary article on Tether/Bitcoin posted on...
    Ehave, Psychedelic Stock Review

    Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

    Research Editor / Curator -
    WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First...

    Biotech Stock Review Adding PetVivo (PETV) $0.23 to the Watch List.

    Biotech News Editor / Curator -
    Are We Catching a Falling Knife? Don't Think So! LIVE QUOTE

    80% Market Crash Coming. David Hunter. (Video)

    Research Editor / Curator -
    https://youtu.be/VNVeJe70U-c
    Richard Werner

    Video: How the Bank of Japan Created a Massive Bubble That Blew Up.

    Research Editor / Curator -
    Fascinating video documentary 'Princes of the Yen: Central Bank Truths' with Banking Expert and Oxford Professor Richard Werner. Werner believes that Central...
    Immunomedics, Biotech Stock Review

    Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

    All News Editor / Curator -
    Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite...
    Citius Pharma

    Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

    Biotech News Editor / Curator -
    STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
    nanovibronix, biotech stock review

    NanoVibronix (NAOV) $3.35, Gets $10.50 Price target from Dawson James.

    Research Editor / Curator -
    Click here for report.
    1...5678Page 6 of 8

    Latest article

    Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

    2022 Watch List Editor / Curator -
    When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

    GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

    2024 Watch List Editor / Curator -
    Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

    NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

    2024 Watch List Editor / Curator -
    Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.